Search results
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 14 hours agoRegeneron and Sanofi could soon be adding another indication to its blockbuster immunology drug ...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 14 hours agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
Regeneron misses profit estimates on weaker Eylea and Dupixent sales
Reuters via Yahoo Finance· 2 weeks agoExcluding items, the company reported a profit of $9.55 per share for the quarter, compared with analysts' estimates of $10.09 per share, according to LSEG data. (Reporting by Sriparna Roy in ...
Moderna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall By Investing.com
Investing.com· 2 weeks agoModerna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall